US Supreme Court appears split on safety labels for Bayer weedkiller Roundup
Case has emerged as one of the biggest ongoing multibillion-dollar corporate tort claims
Related reading
US Supreme Court to hear Bayer’s appeal against weedkiller lawsuits
German group is seeking to end multibillion-dollar litigation alleging its Roundup pesticide causes cancer
Manufacturers start to phase out production of ‘forever chemicals’
Groups including BASF respond to increased risk of litigation over ‘PFAS’ substances and regulatory intervention
Bayer soars on promising trial results for stroke prevention drug
Findings are respite for German conglomerate facing sliding sales of blockbuster drugs and US legal challenges
Short rates have overshot
Plus the social media lawsuits
Merck transforms itself through dealmaking as clock ticks on top-selling drug
Acquisitions fuel pharma group’s evolution as it prepares to lose patent protection on cancer drug Keytruda
Bayer’s ambitions boosted by relaxation of EU gene-edited crop rules
German life sciences giant says looser regulations could reshape Europe’s €6bn seed market